The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 10, 2019
Filed:
Aug. 18, 2015
Applicant:
G-treebnt Co., Ltd., Seongnam-si, Gyeonggi-do, KR;
Inventors:
Sin Wook Kang, Seongnam-si, KR;
Kyoungsun Kim, Busan, KR;
Si Young Lee, Ansan-si, KR;
Ji Hye Sung, Seoul, KR;
Assignee:
G-TREEBNT CO., LTD., Seongnam-si, KR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/22 (2006.01); A61K 9/00 (2006.01); A61K 38/04 (2006.01); A61K 38/16 (2006.01); A61K 38/17 (2006.01); A61K 47/02 (2006.01); A61K 9/08 (2006.01); A61K 47/12 (2006.01);
U.S. Cl.
CPC ...
A61K 38/2292 (2013.01); A61K 9/0048 (2013.01); A61K 9/08 (2013.01); A61K 38/04 (2013.01); A61K 38/16 (2013.01); A61K 38/17 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01);
Abstract
The present invention relates to a therapeutic agent for ophthalmic disease containing thymosin beta 4. The present invention is more effective in reducing xerophthalmia than an ophthalmic solution containing cyclosporine A, is less irritant to eyes than conventional ophthalmic solutions and is physiochemically safe.